BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29899393)

  • 1. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
    Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
    Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
    Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
    Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
    Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
    Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
    Peter E; Treilleux I; Wucher V; Jougla E; Vogrig A; Pissaloux D; Paindavoine S; Berthet J; Picard G; Rogemond V; Villard M; Vincent C; Tonon L; Viari A; Honnorat J; Dubois B; Desestret V
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35821104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
    Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
    Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDR2 antigen and Yo antibodies.
    Totland C; Aarskog NK; Eichler TW; Haugen M; Nøstbakken JK; Monstad SE; Salvesen HB; Mørk S; Haukanes BI; Vedeler CA
    Cancer Immunol Immunother; 2011 Feb; 60(2):283-9. PubMed ID: 21080165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.
    Eichler TW; Totland C; Haugen M; Qvale TH; Mazengia K; Storstein A; Haukanes BI; Vedeler CA
    PLoS One; 2013; 8(6):e66002. PubMed ID: 23823982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
    Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
    J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.
    Bradley WH; Dottino PR; Rahaman J
    Int J Gynecol Cancer; 2008; 18(6):1364-7. PubMed ID: 18217973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
    Meglic B; Graus F; Grad A
    J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies.
    Hillary RP; Ollila HM; Lin L; Desestret V; Rogemond V; Picard G; Small M; Arnulf I; Dauvilliers Y; Honnorat J; Mignot E
    J Neuroimmunol; 2018 Feb; 315():28-32. PubMed ID: 29306402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
    Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
    Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
    Yshii L; Bost C; Liblau R
    Front Immunol; 2020; 11():991. PubMed ID: 32655545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
    Monstad SE; Storstein A; Dørum A; Knudsen A; Lønning PE; Salvesen HB; Aarseth JH; Vedeler CA
    Clin Exp Immunol; 2006 Apr; 144(1):53-8. PubMed ID: 16542365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
    Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
    Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
    J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.